Statement
30 Apr 2026
Sixth resumed meeting of the open-ended Intergovernmental Working Group (IGWG 6) on the WHO Pandemic Agreement: PABS instrument
On 30 April 2026, IFPMA delivered a statement at the Sixth resumed meeting of the open-ended Intergovernmental Working Group (IGWG 6) on the WHO Pandemic Agreement.
Read more
Position paper
20 Apr 2026
Advancing GMP inspection reliance – from pilots to practice
Around the world, National Regulatory Agencies (NRAs) face mounting pressure to ensure access to and availability of high-quality medicinal products while confronted with an increasing number of sites to inspect, a demand driven by a need to strengthen supply resilience and manage limited inspection resources. This position paper represents the views of the research-based biopharmaceutical...
Read more
Statement
24 Mar 2026
WTO 14th Ministerial Conference: An opportunity to address trade, innovation, and health
As WTO Members gather in Yaoundé for the 14th Ministerial Conference (MC14), the meeting comes at a pivotal moment for global trade and health.
Read more